Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins

The binding of purified fibrinogen receptor alpha IIb beta 3, vitronectin receptor alpha V beta 3, and fibronectin receptor alpha 5 beta 1 to their corresponding ligands in solid-phase binding assays was used to examine the inhibitory activity of various linear and cyclic penta- and hexapeptides of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 1994-08, Vol.269 (32), p.20233-20238
Hauptverfasser: Pfaff, M, Tangemann, K, Müller, B, Gurrath, M, Müller, G, Kessler, H, Timpl, R, Engel, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20238
container_issue 32
container_start_page 20233
container_title The Journal of biological chemistry
container_volume 269
creator Pfaff, M
Tangemann, K
Müller, B
Gurrath, M
Müller, G
Kessler, H
Timpl, R
Engel, J
description The binding of purified fibrinogen receptor alpha IIb beta 3, vitronectin receptor alpha V beta 3, and fibronectin receptor alpha 5 beta 1 to their corresponding ligands in solid-phase binding assays was used to examine the inhibitory activity of various linear and cyclic penta- and hexapeptides of different conformation containing RGD or RAD sequences. Cyclic peptides with different defined backbone conformations were designed by introducing a single D-amino acid or a proline at different positions in the ring. The data were calibrated for alpha IIb beta 3 integrin incorporated into a planar lipid bilayer by a physical method (total internal reflection fluorescence microscopy) which yielded KD = 1.7 microM for a linear RGD peptide and KD = 0.03 microM for fibrinogen. With this integrin, three cyclic hexapeptides ([GRGDFL], [ARGDFV], [GRGDFV]) were 2-4-fold more inhibitory than the linear GRGDS peptide in solid-phase assays and showed similar inhibition as the fibrinogen ligand. Six peptides had the same or a 2-fold lower activity as the linear reference peptide, and three peptides were up to 7-fold less active. Replacement of Arg or Asp by their stereoisomers or Gly by Ala resulted in a 100-1000-fold reduction in activity. With the two other integrins, a single cyclic pentapeptide [RGDFV] was 10-fold more active (alpha V beta 3) or equal in activity (alpha 5 beta 1) to linear GRGDS, while all of the other cyclic peptides were moderately or distinctly less active. Changes in the RGD sequence caused a less dramatic reduction in binding strength for alpha V beta 3 and alpha 5 beta 1 than for alpha II beta 3. Inhibitory activity was compared with the distance between the C beta atoms of Arg and Asp residues as determined by NMR and indicated that the optimum distance is in the range of 0.75-0.85 nm for alpha IIb beta 3 and at or below 0.67 nm for alpha V beta 3 and alpha 5 beta 1. This indicates that alpha IIb beta 3 less sensitive to variations in the RGD backbone structure and can accommodate a larger distance than the integrins alpha V beta 3 and alpha 5 beta 1.
doi_str_mv 10.1016/s0021-9258(17)31981-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76637876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76637876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2936-e0c4d34b62bee5152e03d3378a100b308b40022f3717132d848e71a9ba08344d3</originalsourceid><addsrcrecordid>eNpFUdtO3DAQtapWsNB-ApIfEAKJUI-d6yMCCitRkLiJN8t2JrtGSRzsLNX-Al9NwkZ0XkZz5pwZzRlC9oCdAIP0d2CMQ1TwJD-E7EhAkUOUfiMzYLmIRALP38nsi7JNdkJ4YUPEBWyRrZwlABDPyPs91mh6-4bUo3GL1vbWtdRV1KxNbQ29uzynHXa9LTGM8M3fO1piZVssqXFt5XyjPiV6TVXdLRWdzzXV2Csqjifk6X_dlhOWbDCgtu1x4W0bfpIflaoD_pryLnn8c_FwdhVd317Oz06vI8MLkUbITFyKWKdcIyaQcGSiFCLLFTCmBct1PJzNK5FBBoKXeZxjBqrQajAmHqS75GAzt_PudYWhl40NButatehWQWZpOkzL0oGYbIjGuxA8VrLztlF-LYHJ8QfyfjRYjgZLyOTnD-So25sWrHSD5ZdqMn3o72_6S7tY_rMepbbOLLGRPC2k4JIzLoT4AGNZi00</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76637876</pqid></control><display><type>article</type><title>Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Pfaff, M ; Tangemann, K ; Müller, B ; Gurrath, M ; Müller, G ; Kessler, H ; Timpl, R ; Engel, J</creator><creatorcontrib>Pfaff, M ; Tangemann, K ; Müller, B ; Gurrath, M ; Müller, G ; Kessler, H ; Timpl, R ; Engel, J</creatorcontrib><description>The binding of purified fibrinogen receptor alpha IIb beta 3, vitronectin receptor alpha V beta 3, and fibronectin receptor alpha 5 beta 1 to their corresponding ligands in solid-phase binding assays was used to examine the inhibitory activity of various linear and cyclic penta- and hexapeptides of different conformation containing RGD or RAD sequences. Cyclic peptides with different defined backbone conformations were designed by introducing a single D-amino acid or a proline at different positions in the ring. The data were calibrated for alpha IIb beta 3 integrin incorporated into a planar lipid bilayer by a physical method (total internal reflection fluorescence microscopy) which yielded KD = 1.7 microM for a linear RGD peptide and KD = 0.03 microM for fibrinogen. With this integrin, three cyclic hexapeptides ([GRGDFL], [ARGDFV], [GRGDFV]) were 2-4-fold more inhibitory than the linear GRGDS peptide in solid-phase assays and showed similar inhibition as the fibrinogen ligand. Six peptides had the same or a 2-fold lower activity as the linear reference peptide, and three peptides were up to 7-fold less active. Replacement of Arg or Asp by their stereoisomers or Gly by Ala resulted in a 100-1000-fold reduction in activity. With the two other integrins, a single cyclic pentapeptide [RGDFV] was 10-fold more active (alpha V beta 3) or equal in activity (alpha 5 beta 1) to linear GRGDS, while all of the other cyclic peptides were moderately or distinctly less active. Changes in the RGD sequence caused a less dramatic reduction in binding strength for alpha V beta 3 and alpha 5 beta 1 than for alpha II beta 3. Inhibitory activity was compared with the distance between the C beta atoms of Arg and Asp residues as determined by NMR and indicated that the optimum distance is in the range of 0.75-0.85 nm for alpha IIb beta 3 and at or below 0.67 nm for alpha V beta 3 and alpha 5 beta 1. This indicates that alpha IIb beta 3 less sensitive to variations in the RGD backbone structure and can accommodate a larger distance than the integrins alpha V beta 3 and alpha 5 beta 1.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1016/s0021-9258(17)31981-6</identifier><identifier>PMID: 8051114</identifier><language>eng</language><publisher>United States: American Society for Biochemistry and Molecular Biology</publisher><subject>Amino Acid Sequence ; Humans ; Integrins - metabolism ; Ligands ; Magnetic Resonance Spectroscopy ; Molecular Sequence Data ; Oligopeptides - metabolism ; Peptides, Cyclic - metabolism ; Protein Conformation</subject><ispartof>The Journal of biological chemistry, 1994-08, Vol.269 (32), p.20233-20238</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2936-e0c4d34b62bee5152e03d3378a100b308b40022f3717132d848e71a9ba08344d3</citedby><cites>FETCH-LOGICAL-c2936-e0c4d34b62bee5152e03d3378a100b308b40022f3717132d848e71a9ba08344d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8051114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pfaff, M</creatorcontrib><creatorcontrib>Tangemann, K</creatorcontrib><creatorcontrib>Müller, B</creatorcontrib><creatorcontrib>Gurrath, M</creatorcontrib><creatorcontrib>Müller, G</creatorcontrib><creatorcontrib>Kessler, H</creatorcontrib><creatorcontrib>Timpl, R</creatorcontrib><creatorcontrib>Engel, J</creatorcontrib><title>Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The binding of purified fibrinogen receptor alpha IIb beta 3, vitronectin receptor alpha V beta 3, and fibronectin receptor alpha 5 beta 1 to their corresponding ligands in solid-phase binding assays was used to examine the inhibitory activity of various linear and cyclic penta- and hexapeptides of different conformation containing RGD or RAD sequences. Cyclic peptides with different defined backbone conformations were designed by introducing a single D-amino acid or a proline at different positions in the ring. The data were calibrated for alpha IIb beta 3 integrin incorporated into a planar lipid bilayer by a physical method (total internal reflection fluorescence microscopy) which yielded KD = 1.7 microM for a linear RGD peptide and KD = 0.03 microM for fibrinogen. With this integrin, three cyclic hexapeptides ([GRGDFL], [ARGDFV], [GRGDFV]) were 2-4-fold more inhibitory than the linear GRGDS peptide in solid-phase assays and showed similar inhibition as the fibrinogen ligand. Six peptides had the same or a 2-fold lower activity as the linear reference peptide, and three peptides were up to 7-fold less active. Replacement of Arg or Asp by their stereoisomers or Gly by Ala resulted in a 100-1000-fold reduction in activity. With the two other integrins, a single cyclic pentapeptide [RGDFV] was 10-fold more active (alpha V beta 3) or equal in activity (alpha 5 beta 1) to linear GRGDS, while all of the other cyclic peptides were moderately or distinctly less active. Changes in the RGD sequence caused a less dramatic reduction in binding strength for alpha V beta 3 and alpha 5 beta 1 than for alpha II beta 3. Inhibitory activity was compared with the distance between the C beta atoms of Arg and Asp residues as determined by NMR and indicated that the optimum distance is in the range of 0.75-0.85 nm for alpha IIb beta 3 and at or below 0.67 nm for alpha V beta 3 and alpha 5 beta 1. This indicates that alpha IIb beta 3 less sensitive to variations in the RGD backbone structure and can accommodate a larger distance than the integrins alpha V beta 3 and alpha 5 beta 1.</description><subject>Amino Acid Sequence</subject><subject>Humans</subject><subject>Integrins - metabolism</subject><subject>Ligands</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Molecular Sequence Data</subject><subject>Oligopeptides - metabolism</subject><subject>Peptides, Cyclic - metabolism</subject><subject>Protein Conformation</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUdtO3DAQtapWsNB-ApIfEAKJUI-d6yMCCitRkLiJN8t2JrtGSRzsLNX-Al9NwkZ0XkZz5pwZzRlC9oCdAIP0d2CMQ1TwJD-E7EhAkUOUfiMzYLmIRALP38nsi7JNdkJ4YUPEBWyRrZwlABDPyPs91mh6-4bUo3GL1vbWtdRV1KxNbQ29uzynHXa9LTGM8M3fO1piZVssqXFt5XyjPiV6TVXdLRWdzzXV2Csqjifk6X_dlhOWbDCgtu1x4W0bfpIflaoD_pryLnn8c_FwdhVd317Oz06vI8MLkUbITFyKWKdcIyaQcGSiFCLLFTCmBct1PJzNK5FBBoKXeZxjBqrQajAmHqS75GAzt_PudYWhl40NButatehWQWZpOkzL0oGYbIjGuxA8VrLztlF-LYHJ8QfyfjRYjgZLyOTnD-So25sWrHSD5ZdqMn3o72_6S7tY_rMepbbOLLGRPC2k4JIzLoT4AGNZi00</recordid><startdate>19940812</startdate><enddate>19940812</enddate><creator>Pfaff, M</creator><creator>Tangemann, K</creator><creator>Müller, B</creator><creator>Gurrath, M</creator><creator>Müller, G</creator><creator>Kessler, H</creator><creator>Timpl, R</creator><creator>Engel, J</creator><general>American Society for Biochemistry and Molecular Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940812</creationdate><title>Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins</title><author>Pfaff, M ; Tangemann, K ; Müller, B ; Gurrath, M ; Müller, G ; Kessler, H ; Timpl, R ; Engel, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2936-e0c4d34b62bee5152e03d3378a100b308b40022f3717132d848e71a9ba08344d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Amino Acid Sequence</topic><topic>Humans</topic><topic>Integrins - metabolism</topic><topic>Ligands</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Molecular Sequence Data</topic><topic>Oligopeptides - metabolism</topic><topic>Peptides, Cyclic - metabolism</topic><topic>Protein Conformation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pfaff, M</creatorcontrib><creatorcontrib>Tangemann, K</creatorcontrib><creatorcontrib>Müller, B</creatorcontrib><creatorcontrib>Gurrath, M</creatorcontrib><creatorcontrib>Müller, G</creatorcontrib><creatorcontrib>Kessler, H</creatorcontrib><creatorcontrib>Timpl, R</creatorcontrib><creatorcontrib>Engel, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pfaff, M</au><au>Tangemann, K</au><au>Müller, B</au><au>Gurrath, M</au><au>Müller, G</au><au>Kessler, H</au><au>Timpl, R</au><au>Engel, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1994-08-12</date><risdate>1994</risdate><volume>269</volume><issue>32</issue><spage>20233</spage><epage>20238</epage><pages>20233-20238</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The binding of purified fibrinogen receptor alpha IIb beta 3, vitronectin receptor alpha V beta 3, and fibronectin receptor alpha 5 beta 1 to their corresponding ligands in solid-phase binding assays was used to examine the inhibitory activity of various linear and cyclic penta- and hexapeptides of different conformation containing RGD or RAD sequences. Cyclic peptides with different defined backbone conformations were designed by introducing a single D-amino acid or a proline at different positions in the ring. The data were calibrated for alpha IIb beta 3 integrin incorporated into a planar lipid bilayer by a physical method (total internal reflection fluorescence microscopy) which yielded KD = 1.7 microM for a linear RGD peptide and KD = 0.03 microM for fibrinogen. With this integrin, three cyclic hexapeptides ([GRGDFL], [ARGDFV], [GRGDFV]) were 2-4-fold more inhibitory than the linear GRGDS peptide in solid-phase assays and showed similar inhibition as the fibrinogen ligand. Six peptides had the same or a 2-fold lower activity as the linear reference peptide, and three peptides were up to 7-fold less active. Replacement of Arg or Asp by their stereoisomers or Gly by Ala resulted in a 100-1000-fold reduction in activity. With the two other integrins, a single cyclic pentapeptide [RGDFV] was 10-fold more active (alpha V beta 3) or equal in activity (alpha 5 beta 1) to linear GRGDS, while all of the other cyclic peptides were moderately or distinctly less active. Changes in the RGD sequence caused a less dramatic reduction in binding strength for alpha V beta 3 and alpha 5 beta 1 than for alpha II beta 3. Inhibitory activity was compared with the distance between the C beta atoms of Arg and Asp residues as determined by NMR and indicated that the optimum distance is in the range of 0.75-0.85 nm for alpha IIb beta 3 and at or below 0.67 nm for alpha V beta 3 and alpha 5 beta 1. This indicates that alpha IIb beta 3 less sensitive to variations in the RGD backbone structure and can accommodate a larger distance than the integrins alpha V beta 3 and alpha 5 beta 1.</abstract><cop>United States</cop><pub>American Society for Biochemistry and Molecular Biology</pub><pmid>8051114</pmid><doi>10.1016/s0021-9258(17)31981-6</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1994-08, Vol.269 (32), p.20233-20238
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_76637876
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Amino Acid Sequence
Humans
Integrins - metabolism
Ligands
Magnetic Resonance Spectroscopy
Molecular Sequence Data
Oligopeptides - metabolism
Peptides, Cyclic - metabolism
Protein Conformation
title Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A32%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20recognition%20of%20cyclic%20RGD%20peptides%20of%20NMR%20defined%20conformation%20by%20alpha%20IIb%20beta%203,%20alpha%20V%20beta%203,%20and%20alpha%205%20beta%201%20integrins&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Pfaff,%20M&rft.date=1994-08-12&rft.volume=269&rft.issue=32&rft.spage=20233&rft.epage=20238&rft.pages=20233-20238&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1016/s0021-9258(17)31981-6&rft_dat=%3Cproquest_cross%3E76637876%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76637876&rft_id=info:pmid/8051114&rfr_iscdi=true